Top Markets
Coin of the day
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
株式のランク #40
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
株価
$152.37
時価総額
$376.33B
変化(1日)
12.46%
変化(1年)
79.41%
US
取引 Merck & Co., Inc. (MRK)

カテゴリー

Merck & Co., Inc.(MRK)のP/E比率
August 2026 時点のP/E比率 TTM 107.81
Merck & Co., Inc. の最新の財務報告および株価によると、現在の P/E (TTM) は 107.81 です。2024 年末時点での P/E は 14.72 でした。
Merck & Co., Inc. の P/E 比率の履歴(2000 〜 2026)
各年末のP/E比率
P/E比率 変化
2026 (TTM) 107.81 645.57%
2025 14.46 -1.74%
2024 14.72 -98.11%
2023 778.71 3,924.61%
2022 19.35 30.21%
2021 14.86 -46.79%
2020 27.92 23.57%
2019 22.60 -25.59%
2018 30.37 -49.75%
2017 60.43 53.54%
2016 39.36 24.80%
2015 31.54 144.60%
2014 12.89 -59.36%
2013 31.72 65.59%
2012 19.16 9.91%
2011 17.43 -85.89%
2010 123.55 2,069.42%
2009 5.70 -28.19%
2008 7.93 -78.40%
2007 36.72 79.85%
2006 20.42 41.90%
2005 14.39 23.34%
2004 11.67 -19.12%
2003 14.42 -15.38%
2002 17.04 -3.27%
2001 17.62 -41.63%
2000 30.19 0.00%
類似企業や競合他社のP/E比率
企業 P/E比率 P/E比率の差
39.54 -63.33%
US
30.10 -72.08%
US
70.28 -34.81%
US
22.25 -79.36%
CH
22.23 -79.38%
CH
P/E比率の読み方

株価収益率(P/E Ratio)は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の(0に近い)P/Eは、損失が大きいことを示します。

P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。

10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。